MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL)
$43
About Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL)
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Details
Daily high
$402.48
Daily low
$353.54
Price at open
--
52 Week High
$615.00
52 Week Low
$353.54
Market cap
9.2B
Dividend yield
-
Volume
2,303
Avg. volume
396,057
P/E ratio
-66.33
Madrigal Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$402.48
Daily low
$353.54
Price at open
--
52 Week High
$615.00
52 Week Low
$353.54
Market cap
9.2B
Dividend yield
-
Volume
2,303
Avg. volume
396,057
P/E ratio
-66.33